Study of Nivolumab in combination with ipilimumab or standard of care chemotherapy compared to the standard of care chemotherapy

Skip to Content

Clinical Trial Details

Nivolumab in Combination With Ipilimumab Verus Standard of Care Chemotherapy

Study of Nivolumab in combination with ipilimumab or standard of care chemotherapy compared to the standard of care chemotherapy alone in treatment of patients with untreated inoperable or metastatic urothelial cancer.

Objective

Visit the National Cancer Institute's Web Site.

IRB Protocol Number
CA209-901 NCT 03036098

Clinical Trial Categories

  • Bladder Cancer
Contact
NH Oncology Hematology Clinical Research Dept. at 603-224-2556

Location

  • Payson Center for Cancer Care
    250 Pleasant Street
    Concord, NH 03301
    Main: 603-230-6031